Single Topic #3 from April 2026, Volume 19 Issue 4
Product Details
➲ SOLD SEPARATELY not included with online subscriptions
MRONJ (Medication-Related Osteonecrosis of the Jaw)
Brands
Actonel
Atelvia
Boniva
Fosamax
Prolia
Xgeva
Zometa
Atelvia
Boniva
Fosamax
Prolia
Xgeva
Zometa
Abstract
MRONJ (Medication-Related Osteonecrosis of the Jaw)
A must-read clinical guide to MRONJ risk identification and prevention with screening protocols, treatment planning strategies, and patient communication tools.
- MRONJ Checklist for the General Dentist
- Pre-Treatment Planning and Prevention
- Clinical Red Flags
- What To Do If You Suspect MRONJ
- Patient Education
- CR Conclusions
This is one article from the April 2026 issue of Clinicians Report. For the full issue, please go to April 2026.
* Due to immediate access and download, purchase of past issues and single topic articles are non-refundable. CR is a non-profit, educational research institute. Your purchase funds this research.
